HOROWITZ BENJAMIN A

Director Benjamin Horowitz buys 46,337 shares at $18.11 (vs. current $17.28); fifth buy in 12 days amid cluster activity.

Director Benjamin A Horowitz purchased 46,337 shares at $18.11 on 2026-01-07, extending a sequence of five purchases across five trading days (2025-12-26 through 2026-01-07), with three other insiders buying within the same 14-day window. The transaction occurred near the 52-week high of $20.28, and the stock has since declined 14.8%. The company is unprofitable, reporting net income of $-225,389,000.00 against revenue of $194,934,000.00 in the latest quarter, with a market cap of $791,128,010.88. The cluster pattern and rapid succession of buys from Horowitz warrant examination, though the inability to measure outcomes on same-ticker trades and the proximity to the high suggest caution in interpreting conviction.

Director Benjamin Horowitz buys 976,975 shares in 3 tranches totaling $15.9M at blended avg $16.31; holdings reach 8.30M (+13.3%)

Benjamin Horowitz, a Director at Navan Inc., made 3 separate purchases totaling 976,975 shares for $15,938,867.11 between January 2–6, 2026, at prices ranging from $15.77 to $16.74, with a blended average of $16.31. This transaction increased his holdings from 7,323,480 to 8,300,455 shares, representing a 13.3% increase in his existing position. The purchases occurred as the stock traded near the middle of its 52-week range ($12.90–$20.28), and notably, 3 other insiders also bought within the past 14 days, creating a cluster acquisition pattern. The company is currently unprofitable, reporting a quarterly net loss of $225,389,000.00 against revenue of $194,934,000.00, which provides material context for evaluating the conviction behind this substantial director-level purchase.

Director Benjamin Horowitz purchased 1,056,534 shares of NAVN for $16,723,633.14 across 5 transactions (Dec 22-29)

Director Benjamin Horowitz executed 5 separate purchases totaling 1,056,534 shares ($16.7M) over a concentrated 8-day window (Dec 22–29) at prices ranging $15.57–$15.90, with a blended average of $15.83. This represents a 16.9% increase in his holdings to 7,323,480 shares. The transaction occurs while the stock trades at $16.50, just 1.8% above the blended purchase price, and 18.6% below its 52-week high of $20.28. The company is unprofitable (net income of $-225.4M on revenue of $194.9M), indicating the purchase is not motivated by earnings momentum. Notably, a cluster buy pattern is present—4 other insiders also bought within the past 14 days—and Horowitz has 3 prior recent purchases at this ticker (Dec 17–19), suggesting sustained accumulation pressure from the insider group. His cross-ticker track record shows only 3 prior buys, so this represents a material escalation in insider buying intensity at Navan.

Director Horowitz purchases 692,395 shares totaling $9,352,310.10 across three transactions; cluster of 4 other insiders bought in past 14 days amid $-225.4M net loss.

Benjamin A. Horowitz executed 3 separate purchases of 347,600 shares at $12.65 on 2025-12-17, 103,960 shares at $13.61 on 2025-12-18, and 240,835 shares at $14.70 on 2025-12-19, for a blended average price of $13.51 and total outlay of $9,352,310.10. This represents a 12.4% increase in his holdings, bringing his position to 6.27M shares. The purchase pattern coincides with a broader insider cluster: 4 other directors also bought within the past 14 days. Against this backdrop, the company reported a net loss of $-225.4M on revenue of $194.9M in the latest quarter, and the stock trades at $15.11, down 25.5% from its 52-week high of $20.28. The convergence of substantial director-level accumulation during a period of reported losses and depressed valuation warrants attention to the underlying business trajectory and capital allocation rationale.